Oncology - Medicine.net

Nature: Multiple Breakthroughs in Vaccine Technology

Recently, Nature has successively published groundbreaking vaccine research results, attracting widespread attention.

Updated on: February 18,2025

Nature: Multiple Breakthroughs in Vaccine Technology

Recently, Nature has successively published groundbreaking vaccine research results, attracting widespread attention.

Updated on:February 18,2025

Advancing gene therapy for skin cancer

by Federica Giannelli,University of SaskatchewanStudent Mays Al-Dulaymi improves gene therapy techniques. Credit: Dave StobbeOne of the deadliest skin cancers, melanoma may be caused by overexpo

Updated on: December 18,2023

Advancing gene therapy for skin cancer

by Federica Giannelli,University of SaskatchewanStudent Mays Al-Dulaymi improves gene therapy techniques. Credit: Dave StobbeOne of the deadliest skin cancers, melanoma may be caused by overexpo

Updated on:December 18,2023

UGN-101 reviewed in real-world upper tract urothelial cancer setting

by Elana GotkineFor patients with upper tract urothelial cancers (UTUCs), the novel therapeutic UGN-101 seems to be effective, with an acceptable safety profile, according to research published online

Updated on: December 17,2023

UGN-101 reviewed in real-world upper tract urothelial cancer setting

by Elana GotkineFor patients with upper tract urothelial cancers (UTUCs), the novel therapeutic UGN-101 seems to be effective, with an acceptable safety profile, according to research published online

Updated on:December 17,2023

Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chancesbyFlinders UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A new study shows that cerebrospinal fluid reduces c

Updated on: October 30,2023

Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chancesbyFlinders UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A new study shows that cerebrospinal fluid reduces c

Updated on:October 30,2023

Hormonal breast cancer treatment reduces long-term risk of recurrence

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of

Updated on: December 18,2023

Hormonal breast cancer treatment reduces long-term risk of recurrence

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of

Updated on:December 18,2023

AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer

byJohns Hopkins University School of MedicineCredit: Carolyn Hruban, Ph.D.A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers coul

Updated on: October 30,2024

AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer

byJohns Hopkins University School of MedicineCredit: Carolyn Hruban, Ph.D.A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers coul

Updated on:October 30,2024

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha

Updated on: December 19,2023

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha

Updated on:December 19,2023

Technology that determines success of CAR T-cell immunotherapy could advance treatment of lymphoma

by Laurie Fickman,University of HoustonNavin Varadarajan, M.D. Anderson Professor of chemical and biomolecular engineering, studied the dynamic interactions between T cells and tumor cells to de

Updated on: December 26,2023

Technology that determines success of CAR T-cell immunotherapy could advance treatment of lymphoma

by Laurie Fickman,University of HoustonNavin Varadarajan, M.D. Anderson Professor of chemical and biomolecular engineering, studied the dynamic interactions between T cells and tumor cells to de

Updated on:December 26,2023

Step forward in leukemia treatment

by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen

Updated on: December 22,2023

Step forward in leukemia treatment

by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen

Updated on:December 22,2023

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v

Updated on: October 24,2023

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v

Updated on:October 24,2023

Talazoparib + enzalutamide beneficial in metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according